Gyre Therapeutics, Inc. (GYRE)

Gyre Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	15.05	11.81	33.51	25.18
Short-Term Investments	14.85	14.86	-	-
Cash & Short-Term Investments	29.89	26.67	33.51	25.18
Cash Growth	-19.98%	-20.41%	33.10%	-
Accounts Receivable	20.15	19.59	15.16	15.61
Other Receivables	0.23	5.19	1.29	-
Receivables	22.52	29.15	16.84	17.14
Inventory	7.88	6.34	4.28	6.12
Prepaid Expenses	8.16	1.19	1.55	0.38
Other Current Assets	-	1.44	1.05	0.84
Total Current Assets	68.45	64.79	57.22	49.65
Property, Plant & Equipment	23.52	25.7	23.78	18.38
Long-Term Investments	21.37	24.57	23.43	7.39
Other Intangible Assets	5.08	1.71	1.7	1.86
Long-Term Deferred Tax Assets	5.82	5.62	4.7	4.08
Other Long-Term Assets	5.56	3.03	5.72	3.39
Total Assets	129.79	125.41	116.54	84.75
Accounts Payable	0.12	0.11	0.36	0.12
Accrued Expenses	17.24	9.3	10.56	6.77
Current Portion of Leases	0.81	0.71	0.21	0.49
Current Income Taxes Payable	0.57	2.83	5.05	2.1
Current Unearned Revenue	0.03	0.16	0.08	0.17
Other Current Liabilities	0.23	6.41	3.79	2.59
Total Current Liabilities	18.99	19.52	20.05	12.24
Long-Term Leases	0.78	0.89	0.2	0.12
Long-Term Unearned Revenue	0.91	0.93	0.21	0.12
Other Long-Term Liabilities	4.81	5.68	17.61	0.06
Total Liabilities	25.49	27	38.07	12.54
Common Stock	0.09	0.09	0.08	0.06
Additional Paid-In Capital	138.18	136.19	68.18	32.8
Retained Earnings	-67.66	-70.36	-82.44	10.06
Comprehensive Income & Other	-2.49	-2.6	-1.64	-0.39
Total Common Equity	68.12	63.32	-15.83	42.52
Minority Interest	36.18	35.08	29.78	29.7
Shareholders' Equity	104.3	98.4	78.47	72.22
Total Liabilities & Equity	129.79	125.41	116.54	84.75
Total Debt	1.59	1.6	0.41	0.61
Net Cash (Debt)	28.31	25.07	33.1	24.56
Net Cash Growth	-23.66%	-24.25%	34.76%	-
Net Cash Per Share	0.28	0.25	0.50	0.32
Filing Date Shares Outstanding	86.31	93.61	85.42	63.59
Total Common Shares Outstanding	86.31	86.31	76.6	63.59
Working Capital	49.46	45.27	37.17	37.41
Book Value Per Share	0.79	0.73	-0.21	0.67
Tangible Book Value	63.04	61.61	-17.53	40.67
Tangible Book Value Per Share	0.73	0.71	-0.23	0.64
Buildings	-	18.98	12.29	10.84
Machinery	-	10.28	7.39	5.69
Construction In Progress	-	0.22	7.88	4.85
Leasehold Improvements	-	-	-	0.33

Updated May 9, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q